NEWS and OPINIONS
Artificial wombs, after years in development, reach FDA review for human trials
By Lizzy Lawrence - Stat The artificial womb, a device aiming to save infants born way too soon, is inching closer to being tested in humans. The technology is close enough to reality that the Food and Drug Administration has decided to convene a two-day panel...
Worms With a Superpower – Stanford Scientists Unravel Secrets of Regeneration
By Stanford University School of Engineering - SciTech Daily When an injury occurs in many organisms, a whole-body response is triggered, possibly aiding in healing and regeneration; this is seen in mice, axolotls, zebrafish, and planarian worms. In planarians,...
CAR-T cell researchers at Mayo Clinic optimistic about future of treating blood cancers
By Kelley Luckstein - Mayo Clinic ROCHESTER, Minn. — Survival outcomes using chimeric antigen receptor-T cell therapy (CAR-T cell therapy) continue to be impressive for patients with some blood cancers. “Five years ago, the survival rate for people with blood cancers...
Lawsuit alleges businesses sold fraudulent stem cell therapy to 250 Iowans totaling $1M
Noelle Alviz-Gransee - Des Moines Register Iowa Attorney General Brenna Bird sued two businesses and their owners for allegedly selling fraudulent stem cell therapy treatments to more than 250 Iowans. The lawsuit filed against Biologics Health LLC, Summit Partners...
Bioengineered instrument reveals hidden cancer cells
By Taylor Mixides - Drug Target Review Scientists at Stanford University have engineered a biomolecule that can specifically remove mucins from cancer cells. This breakthrough could have a significant impact on future cancer therapies. Cancer cells can elude the...
From Lift Off to Splash Down: An Update on Mayo Clinic Stem Cells in Space
By Lynda De Widt - Mayo Clinic Growing up in Nigeria, Dr. Zubair had high ambitions, including dreams of becoming an astronaut. Though he has not taken flight, his work has – literally. In 2017, several samples of donated stem cells from Dr. Zubair's lab were on...
NASA, Partners Clear Axiom Space’s Third Private Astronaut Crew
By NASA NASA and its international partners approved the crew for Axiom Space’s third private astronaut mission to the International Space Station, launching from the agency’s Kennedy Space Center in Florida no earlier than January 2024. Axiom Space’s chief astronaut...
Ian Wilmut, Scientist Behind Dolly the Cloned Sheep, Is Dead at 79
By Clay Risen and Amanda Holpuch - The New York Times Ian Wilmut, the British scientist who led the project that cloned a mammal for the first time, Dolly the sheep, shocking scientists who had thought that such a procedure was impossible, died on Sunday. He was 79....
CRISPR used to ‘reprogram’ cancer cells into healthy muscle in the lab
by Live Science Scientists have transformed cancer cells into healthy muscle tissue in the lab using CRISPR gene-editing technology — and they hope new cancer treatments can be built on the back of this experiment. In a study published Aug. 28 in the journal PNAS,...
Gene therapy for brain tumor shows promising early results in humans
by Ann Megdell - Michigan Medicine A study from the University of Michigan Department of Neurosurgery and Rogel Cancer Center shows promising early results that a therapy combining cell-killing and immune-stimulating drugs are safe and effective in extending survival...
Single Dose of CRISPR Treatment Removes HIV-Like Virus From Monkey Genome
by Technology Networks News A single injection of a novel CRISPR gene-editing treatment safely and efficiently removes SIV – a virus related to the AIDS-causing agent HIV – from the genomes of non-human primates, scientists at the Lewis Katz School of Medicine at...
Obituary: Professor Sir Ian Wilmut
by University of Edinburgh A world-renowned embryologist and specialist in regenerative medicine, Sir Ian led the team that cloned Dolly the Sheep in 1996 – the first mammal to be cloned from an adult cell. Some 27 years on, the breakthrough continues to fuel many of...